Combiprasal 0.5 mg / 2.5 mg per 2.5 ml nebuliser solution
- Licence status
- Active substances
- Ipratropium bromide, SALBUTAMOL SULFATE
- Dosage Form
- Nebuliser solution
- Licence number
- PA1815/001/001
- Licence holder
- Pharma Stulln GmbH
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- R03AL Adrenergics in combination with anticholinergics, R03AL02 salbutamol and ipratropium bromide
- Legal supply status
- Product subject to prescription which may be renewed (B)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 10/01/2014